First American Trust’s Biogen BIIB Stock Holding History

First American Trust’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-11,567	Closed	-$2.73M	–	125
2019 Q1	$2.73M	Buy	11,567 +236	+2%	+$74.3K	0.6%	64
2018 Q4	$3.41M	Sell	11,331 -211	-2%	-$67.3K	0.86%	42
2018 Q3	$4.08M	Buy	11,542 +63	+0.5%	+$21.7K	0.91%	45
2018 Q2	$3.33M	Buy	11,479 +869	+8%	+$244K	0.78%	50
2018 Q1	$2.9M	Buy	10,610 +481	+5%	+$149K	0.71%	53
2017 Q4	$3.23M	Buy	+10,129	New	+$3.25M	0.79%	48

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

First American Trust's BIIB Position: Q2 2019 in Review

First American Trust sold out of Biogen (BIIB) in Q2 2019, closing a stake of 11,567 shares — an estimated $2.73M sold.

First American Trust first reported a position in BIIB in Q4 2017 and held it in 6 quarters. The position peaked at $4.08M in Q3 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

First American Trust reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
First American Trust sold 11,567 Biogen shares in Q2 2019, an estimated $2.73M.
First American Trust first reported a position in Biogen in Q4 2017 and held it in 6 quarters.
First American Trust's Biogen position peaked at $4.08M in Q3 2018.
1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on First American Trust's 13F filing for Q2 2019, filed 8 Jul 2019.